A leader in human data science, IQVIA is also known as IMS Health and Quintiles, recently announced the launch of the Avacare Clinical Research Network previously known as Qcare.
Avacare is a technology-based global site network that enables opportunities for more clinical trials at experienced clinical and research sites.
It uses innovative technology with advanced analytics to deliver artificial intelligence-powered patient referrals and data-driven enrollment trends. Avacare utilizes proprietary algorithms and private health records of each site to identify the best patient to engage in the respective clinical trial.
Avacare, with a coverage of over 19 therapeutic areas has since then expanded by including sites across the United States of America and India.
Cynthia Verst (President, Design & Delivery Innovation, R&D Solutions) at IQVIA, says that through Avacare which combines both clinical research and patient care, will help in producing better outcomes, cost of care and advances research that will benefit the patients.
Avacare’s unique analytical tools help sites in Avacare’s network in matching patients to clinical trials faster and more effectively.
Through existing past medical relationships that are connected to approximately 6.5 million patients globally, Avacare provides innovative treatment options that drive healthcare forward.